Ohio medical regulators raise concerns over retail IV therapy clinics
UC liver transplant expert spoke on Cincinnati Edition
On May 15, the State Medical Board of Ohio, Ohio Board of Pharmacy and Ohio Board of Nursing issued a joint regulatory statement addressing patient safety concerns when it comes to retail IV therapy clinics. The clinics administer a combination of saline, vitamins, electrolytes and amino acids, as well as headache relief and anti-nausea medications through an intravenous drip. Clinics in the Cincinnati area have made claims that their treatments can cure hangovers and dehydration better than water alone, while also boosting immunity, improving gut health and maintaining healthy joints.
On Cincinnati Edition on 91.7 WVXU News, experts including the University of Cincinnati's Michael (Mick) Schoech, MD, talked about the risks associated with retail IV hydration and if these services offer effective solutions to the health concerns they target.
Schoech is an associate professor in the Division of Digestive Diseases in the Department of Internal Medicine in the UC College of Medicine and director of UC Health's transplant hepatology program.
"Typically, with a hangover, you're getting symptoms as your blood alcohol level nears zero, so headache, fatigue, nausea, anxiety, sensitivity to light and sound, poor concentration," said Schoech. "So, IV fluids are really treating only one part of the problem that is the dehydration associated with it, and it's not going to speed up the process of recovering from a hangover. Really it's time, rest and rehydrating, and IV fluids aren't typically going to counteract those effects."
Schoech went on to say that typically rehydrating with water is a more cost-effective way to treat a hangover.
"There is no evidence to support that IV hydration for minor flu-like symptoms, jet lag and hangovers has any benefit to the person or kind of speeding up the recovery from either or those conditions," he said.
"It's really about drinking in moderation," said Schoech. "And there's really no easy, quick fix that's going to undue the effects of alcohol."
Listen as Schoech described possible risks involved with getting an IV.
Featured image at top: Michael (Mick) Schoech, MD, inside the WVXU studios. Photo/Megan Burgasser/UC Media Relations + Content.
Related Stories
UC studies: Silent mutations, tumor microenvironment may be therapeutic targets
April 17, 2026
University of Cincinnati Cancer Center researchers will present abstracts at the American Association for Cancer Research Annual Meeting 2026 April 17 to 22 in San Diego.
New UC Blue Ash business officer is a familiar face on campus
April 17, 2026
Lacey McCarthy will bring her skills, expertise and more than 20 years of experience in budget and financing to her new role as business officer for the University of Cincinnati Blue Ash College.
UC experts present neurology research at national conference
April 17, 2026
University of Cincinnati researchers will present abstracts at the 2026 American Academy of Neurology Annual Meeting April 18 to 22 in Chicago.